Top

Published in:

01-09-2017 | Original Paper

Assessing the Impact of Perinatal HIV Case Management on Outcomes Along the HIV Care Continuum for Pregnant and Postpartum Women Living With HIV, Philadelphia 2005–2013

Authors: Emily A. Anderson, Florence M. Momplaisir, Catherine Corson, Kathleen A. Brady

Published in: AIDS and Behavior | Issue 9/2017

Abstract

To evaluate the impact of a Perinatal Medical Case Management (PCM) Program for women living with HIV (WLWH). Characteristics of pregnant and postpartum WLWH were compared between those who engaged in PCM and those who did not. Using secondary data collected from routine HIV surveillance, multivariable regression models were used to evaluate the association between PCM and four outcomes adapted from the HIV care continuum. In multivariable models, compared to WLWH not in PCM, participants (n = 448, 52.8%) were almost twice as likely to achieve HIV suppression before delivery (aOR 1.90 [1.33, 2.71], p = 0.0005); were more likely to be retained in HIV care 1 year postpartum (aOR 1.59 [1.17, 2.16], p = 0.0029); and were equally likely to engage in HIV care within 90-days of delivery (aOR 1.21 [0.88, 1.65], p = 0.236) and be virally suppressed 1 year postpartum (aOR 1.26 [0.90, 1.77], p = 0.178). PCM is an important intervention for preventing perinatal HIV transmission and closings gaps in the HIV care continuum for WLWH during pregnancy and postpartum.

Centers for Disease Control and Prevention. HIV among pregnant women, infants, and children. 2016. https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html. Accessed 25 Nov 2016.

Centers for Disease Control and Prevention. HIV Among Women. 2016. https://www.cdc.gov/hiv/group/gender/women/. Accessed 12 Dec 2016.

Hess K, Hu X, Lansky A, Mermin J, Hall HI. Estimating the lifetime risk of a diagnosis of HIV infection in the United States. Paper presented at: CROI; 24 Feb 2016; Boston, MA.

Whitmore SK, Taylor AW, Espinoza L, Shouse RL, Lampe MA, Nesheim S. Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics. 2012;129(1):e74–81.CrossRefPubMed

Camacho-Gonzalez AF, Kingbo MH, Boylan A, Eckard AR, Chahroudi A, Chakraborty R. Missed opportunities for prevention of mother-to-child transmission in the United States. AIDS. 2015;29(12):1511–5.CrossRefPubMedPubMedCentral

Kalichman SC, Grebler T. Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS. Psychosom Med. 2010;72(8):810–6.CrossRefPubMedPubMedCentral

Gielen AC, Ghandour RM, Burke JG, Mahoney P, McDonnell KA, O’Campo P. HIV/AIDS and intimate partner violence: intersecting women’s health issues in the United States. Trauma Violence Abuse. 2007;8(2):178–98.CrossRefPubMed

Kapetanovic S, Christensen S, Karim R, et al. Correlates of perinatal depression in HIV-infected women. AIDS Patient Care STDS. 2009;23(2):101–8.CrossRefPubMedPubMedCentral

Philadelphia Department of Public Health. Archived AIDS Activities Coordinating Office HIV surveillance reports. http://www.phila.gov/health/aaco/aacodataresearch.html. Accessed 30 Nov 2016.

10.

Momplaisir FM, Brady KA, Fekete T, Thompson DR, Diez Roux A, Yehia BR. Time of HIV diagnosis and engagement in prenatal care impact virologic outcomes of pregnant women with HIV. PLoS ONE. 2015;10(7):e0132262. doi:10.1371/journal.pone.0132262.CrossRefPubMedPubMedCentral

11.

Adams JW, Brady KA, Michael YL, Yehia BR, Momplaisir FM. Postpartum engagement in HIV care: an important predictor of long-term retention in care and viral suppression. Clin Infect Dis. 2015;61(12):1880–7.CrossRefPubMed

12.

Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2015. http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed 28 Nov 2016.

13.

Nachega JB, Uthman OA, Anderson J, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012;26(16):2039–52.CrossRefPubMedPubMedCentral

14.

Mellins CA, Chu C, Malee K, et al. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care. 2008;20(8):958–68.CrossRefPubMed

15.

Katz MH, Cunningham WE, Fleishman JA, et al. Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. Ann Intern Med. 2001;135(8 Part 1):557–65.CrossRefPubMed

16.

Magnus M, Schmidt N, Kirkhart K, et al. Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. AIDS Patient Care STDS. 2001;15(3):137–45.CrossRefPubMed

17.

Philadelphia Department of Public Health. AIDS Activities Coordinating Office (AACO) Perinatal Medical Case Management Standards. [unpublished standard]. Philadelphia, PA: AIDS Activities Coordinating Office; 2012.

18.

Pediatric AIDS Chicago Prevention Initiative. Enhanced case management. 2016. http://www.pregnantandpositive.org/programs/enhanced-case-management/. Accessed 4 Nov 2016.

19.

Los Angeles Department of Public Health. Los Angeles County standards for perinatal HIV prevention and care. 2005. http://publichealth.lacounty.gov/wwwfiles/ph/hae/hiv/LOS_ANGELES_COUNTY_STANDARDS_FOR_PERINATAL_HIV_PREVENTION.pdf. Accessed 28 Oct 2016.

20.

Centers for Disease Control and Prevention. Enhanced perinatal surveillance-15 areas, 2005-2008. HIV Surveillance Supplemental Report. April 2011; 16(No.2). http://www.cdc.gov/hiv/pdf/statistics_2005_2008_HIV_Surveillance_Report_vol_16_no2.pdf. Accessed 6 Oct 2016.

21.

Dean BB, Hart RL, Buchacz K, et al. HIV laboratory monitoring reliably identifies persons engaged in care. J Acquir Immune Defic Syndr. 2015;68(2):133–9.CrossRefPubMedPubMedCentral

22.

Rebeiro P, Althoff KN, Lau B, et al. Laboratory measures as proxies for primary care encounters: implications for quantifying clinical retention among HIV-infected adults in North America. Am J Epidemiol. 2015;182(11):952–60.CrossRefPubMedPubMedCentral

23.

United States Department of Health and Human Services Health Resources Service Administration. HIV/AIDS Bureau core performance measures. 2013; http://hab.hrsa.gov/deliverhivaidscare/coremeasures.pdf. Accessed 20 Nov 2016.

24.

Panel on antiretroviral guidelines for adults and adolescents. Archived adult and adolescent guidelines: guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. 2016. https://aidsinfo.nih.gov/guidelines/archive/adult-and-adolescent-guidelines. Accessed 2 Nov 2016.

25.

Kessner DM, Institute of Medicine Panel on Health Services Research. Infant death: an analysis by maternal risk and health care. Vol 1. Washington, DC: Institute of Medicine; 1973.

26.

Hart JE, Jeon CY, Ivers LC, et al. Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr. 2010;54(2):167–79.PubMedPubMedCentral

27.

Mbuagbaw L, Sivaramalingam B, Navarro T, et al. Interventions for enhancing adherence to antiretroviral therapy (ART): a systematic review of high quality studies. AIDS Patient Care STDS. 2015;29(5):248–66.CrossRefPubMedPubMedCentral

28.

Higa DH, Marks G, Crepaz N, Liau A, Lyles CM. Interventions to improve retention in HIV primary care: a systematic review of U.S. studies. Curr HIV/AIDS Rep. 2012;9(4):313–25.CrossRefPubMed

29.

Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Bärnighausen T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS. 2014;28(Suppl 2):S187–204.CrossRefPubMed

30.

Melekhin VV, Shepherd BE, Jenkins CA, et al. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States. AIDS Patient Care STDS. 2010;24(5):279–86.CrossRefPubMedPubMedCentral

31.

Quinlivan EB, Fletcher J, Eastwood EA, Blank AE, Verdecias N, Roytburd K. Health status of HIV-infected women entering care: baseline medical findings from the women of color initiative. AIDS Patient Care STDS. 2015;29(Suppl 1):S11–9.CrossRefPubMedPubMedCentral

32.

Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA. 2011;285(11):1466–74.CrossRef

33.

Rubin LH, Cook JA, Grey DD, et al. Perinatal depressive symptoms in HIV-infected versus HIV-uninfected women: a prospective study from preconception to postpartum. J Women’s Health. 2011;20(9):1287–95.CrossRef

34.

Buchberg MK, Fletcher FE, Vidrine DJ, et al. A mixed-methods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women. AIDS Patient Care STDS. 2015;29(3):126–32.CrossRefPubMedPubMedCentral

35.

Lambert JS, Avramovic G, Jackson V, Sammon N, Lally S, Campbell FJ. Investigation into the reasons for maternal default from HIV care postpartum: a 3-year retrospective review. AIDS Patient Care STDS. 2014;28(1):1–3.CrossRefPubMed

36.

Stein MD, Crystal S, Cunningham WE, et al. Delays in seeking HIV care due to competing caregiver responsibilities. Am J Public Health. 2000;90(7):1138–40.CrossRefPubMedPubMedCentral

37.

Martin M, Del Cacho E, Codina C, et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. AIDS Res Hum Retroviruses. 2008;24(10):1263–8.CrossRefPubMed

38.

Puskas CM, Forrest JI, Parashar S, et al. Women and vulnerability to HAART non-Adherence: a literature review of treatment adherence by gender from 2000 to 2011. Curr HIV/AIDS Rep. 2011;8(4):277–87.CrossRefPubMed

39.

Rosen S, Maskew M, Fox MP, et al. Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS Med. 2016;13(5):e1002015. doi:10.1371/journal.pmed.1002015.CrossRefPubMedPubMedCentral

Title: Assessing the Impact of Perinatal HIV Case Management on Outcomes Along the HIV Care Continuum for Pregnant and Postpartum Women Living With HIV, Philadelphia 2005–2013
Authors: Emily A. Anderson
Florence M. Momplaisir
Catherine Corson
Kathleen A. Brady
Publication date: 01-09-2017
Publisher: Springer US
Published in: AIDS and Behavior / Issue 9/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-017-1714-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Assessing the Impact of Perinatal HIV Case Management on Outcomes Along the HIV Care Continuum for Pregnant and Postpartum Women Living With HIV, Philadelphia 2005–2013

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2017

Psychological Stressors and Coping Strategies Used by Adolescents Living with and Not Living with Hiv Infection in Nigeria

Effectiveness of a Brief Multi-Component Intervention to HIV Prevention Among Spanish Youth

Stigma Management Trajectories in Youth with Perinatally Acquired HIV and Their Families: A Qualitative Perspective

Gender, HIV Testing and Stigma: The Association of HIV Testing Behaviors and Community-Level and Individual-Level Stigma in Rural South Africa Differ for Men and Women

Erratum to: Contributions of Disease Severity, Psychosocial Factors, and Cognition to Behavioral Functioning in US Youth Perinatally Exposed to HIV

Maternal Influences on Access to and Use of Infant ARVs and HIV Health Services in Uganda

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page